Long-read RNA sequencing atlas of human microglia isoforms elucidates disease-associated genetic regulation of splicing
- PMID: 40033057
- DOI: 10.1038/s41588-025-02099-0
Long-read RNA sequencing atlas of human microglia isoforms elucidates disease-associated genetic regulation of splicing
Abstract
Microglia, the innate immune cells of the central nervous system, have been genetically implicated in multiple neurodegenerative diseases. Mapping the genetics of gene expression in human microglia has identified several loci associated with disease-associated genetic variants in microglia-specific regulatory elements. However, identifying genetic effects on splicing is challenging because of the use of short sequencing reads. Here, we present the isoform-centric microglia genomic atlas (isoMiGA), which leverages long-read RNA sequencing to identify 35,879 novel microglia isoforms. We show that these isoforms are involved in stimulation response and brain region specificity. We then quantified the expression of both known and novel isoforms in a multi-ancestry meta-analysis of 555 human microglia short-read RNA sequencing samples from 391 donors, and found associations with genetic risk loci in Alzheimer's and Parkinson's disease. We nominate several loci that may act through complex changes in isoform and splice-site usage.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: The following authors wish to disclose their industry relations: A.M.G. is a scientific advisory board member for Genentech and Muna Therapeutics; R.S. is currently a paid consultant and equity holder at GeneDx; N.F. is currently an employee of Pacific Biosciences; B.Z.M. is currently an employee of Abbvie; A.G.E. is an employee of BlueRock Therapeutics. All other authors declare no competing interests.
Update of
-
Long-read RNA-seq atlas of novel microglia isoforms elucidates disease-associated genetic regulation of splicing.medRxiv [Preprint]. 2023 Dec 1:2023.12.01.23299073. doi: 10.1101/2023.12.01.23299073. medRxiv. 2023. Update in: Nat Genet. 2025 Mar;57(3):604-615. doi: 10.1038/s41588-025-02099-0. PMID: 38076956 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
- R21-AG063130/Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- R01-AG054005/Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- U01-AG068880/Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- U01-AG058635/Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
LinkOut - more resources
Full Text Sources
Medical